Peter Gergics

Peter Gergics

Auto-generated profile, based on publicly available information

Peter Gergics

Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2018 in Endocrinology
Verified
Journal Article
Closed access
PDF file
LCLeonard Y M Cheung
Leonard Y M Cheung
AGAkima S George
Akima S George
SMStacey R McGee
Stacey R McGee
ADAlexandre Z Daly
Alexandre Z Daly
MBMichelle L Brinkmeier
Michelle L Brinkmeier
SCSally A Camper
Sally A Camper
Transcription factors and signaling pathways that regulate stem cells and specialized hormone-producing cells in the pituitary gland have been the subject of intense study and have yielded a mechanistic understanding of pituitary organogenesis and disease. Yet, the regulation of stem cell proliferation and differentiation, the heterogeneity among specialized hormone-producing cells, and the role of non-endocrine cells in the gland remain important, unanswered questions. Recent advances in single-cell RNA sequencing (scRNAseq) technologies provide new avenues to address these questions. We performed scRNAseq on approximately 13,663 cells pooled from six whole pituitary glands of 7-week-old C57BL/6 male mice. We identified pituitary endocrine and stem cells in silico, as well as other support cell-types such as endothelia, connective tissue, and red and white blood cells. Differential gene expression analyses identify known and novel markers of pituitary endocrine and stem cell populations. We demonstrate the value of scRNAseq by in vivo validation of a novel gonadotrope-enriched marker, Foxp2. We present novel scRNAseq data of in vivo pituitary tissue, including data from agnostic clustering algorithms which suggest the presence of a somatotrope subpopulation enriched in sterol/cholesterol synthesis genes. At the same time, we show that incomplete transcriptome annotation can cause false negatives on some scRNAseq platforms that only generate 3’ transcript end sequences, and use in vivo data to recover reads of the pituitary transcription factor Prop1. Ultimately, scRNAseq technologies represent a significant opportunity to address longstanding questions regarding the development and function of the different populations of the pituitary gland throughout life.

1 July 2021 in European Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
LGLouise C Gregory
Louise C Gregory
PGPeter Gergics
Peter Gergics
MNMarilena Nakaguma
Marilena Nakaguma
HBHironori Bando
Hironori Bando
GPGiuseppa Patti
Giuseppa Patti
MDMehul T Dattani
Mehul T Dattani
Objective: The transcription factor OTX2is implicated in ocular, craniofacial, and pituitary development. Design: We aimed to establish the contribution of OTX2 mutations in congenital hypopituitarism patients with/without eye abnormalities, study functional consequences, and establish OTX2 expression in the human brain, with a view to investigate the mechanism of action. Methods: We screened patients from the UK (n = 103), international centres (n = 24), and Brazil (n = 282); 145 were within the septo-optic dysplasia spectrum, and 264 had no eye phenotype. Transactivation ability of OTX2 variants was analysed in murine hypothalamic GT1-7 neurons. In situ hybridization was performed on human embryonic brain sections. Genetically engineered mice were generated with a series of C-terminal OTX2 variants. Results: Two chromosomal deletions and six haploinsufficient mutations were identified in individuals with eye abnormalities; an affected relative of one patient harboured the same mutation without an ocular phenotype. OTX2 truncations led to significant transactivation reduction. A missense variant was identified in another patient without eye abnormalities; however, studies revealed it was most likely not causative. In the mouse, truncations proximal to aa219 caused anophthalmia, while distal truncations and the missense variant were tolerated. During human embryogenesis, OTX2 was expressed in the posterior pituitary, retina, ear, thalamus, choroid plexus, and partially in the hypothalamus, but not in the anterior pituitary. Conclusions: OTX2 mutations are rarely associated with hypopituitarism in isolation without eye abnormalities, and may be variably penetrant, even within the same pedigree. Our data suggest that the endocrine phenotypes in patients with OTX2 mutations are of hypothalamic origin.

1 May 2009 in Wiener klinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
JTJudit Tőke
Judit Tőke
APAttila Patocs
Attila Patocs
KBKatalin Balogh
Katalin Balogh
PGPéter Gergics
Péter Gergics
BSBalázs Stenczer
Balázs Stenczer
MTMiklós Tóth
Miklós Tóth

8 February 2021 in medRxiv
Verified
Preprint
Open access
PDF file
PGPeter Gergics
Peter Gergics
CSCathy Smith
Cathy Smith
HBHironori Bando
Hironori Bando
AJAlexander Augusto Lima Jorge
Alexander Augusto Lima Jorge
DRDenise Rockstroh-Lippold
Denise Rockstroh-Lippold
SCSally Camper
Sally Camper
Pituitary hormone deficiency occurs in ∼1:4,000 live births. Approximately 3% of the cases are due to mutations in the alpha isoform of POU1F1, a pituitary-specific transcriptional activator. We found four separate heterozygous missense variants in unrelated hypopituitarism patients that were predicted to affect a minor isoform, POU1F1 beta, which can act as a transcriptional repressor. These variants retain repressor activity, but they shift splicing to favor the expression of the beta isoform, resulting in dominant negative loss of function. Using a high throughput splicing reporter assay, we tested 1,080 single nucleotide variants in POU1F1 . We identified 113 splice disruptive variants, including 23 synonymous variants. We evaluated separate cohorts of hypopituitarism patients and found two different synonymous splice disruptive variants that co-segregate with hypopituitarism. This study underlines the importance of evaluating the impact of variants on splicing and provides a catalog for interpretation of variants of unknown significance in the POU1F1 gene.

1 April 2008 in Gastroenterology
Verified
Journal Article
Open access
PDF file
EMEmese Mihály
Emese Mihály
PGPéter Gergics
Péter Gergics
PMPál Miheller
Pál Miheller
KRKároly Rácz
Károly Rácz
ZTZsolt Tulassay
Zsolt Tulassay